FDA Panel Endorses Moderna ‘Half Dose’ Booster Six Months After 2nd Dose
A vaccination advisory panel for the Food and Drug Administration unanimously endorsed the authorization of emergency approval for the Moderna half-dose booster shot for at-risk Americans that received their second vaccination shot at least six months ago.
The panel, consisting of outside advisers, voted 19-0 Thursday in favor of authorizing the booster to adults 65 years and older as well as adults ages 18 and up who may have other health conditions, jobs, or living situations that put them that at greater risk of infection.
The FDA authorized a Pfizer booster last month for the same at-risk groups that the panel determined should also get the Moderna booster.
Read More at the New York Post
